Gotham Asset Management LLC Makes New Investment in Encompass Health Co. (NYSE:EHC)

Gotham Asset Management LLC acquired a new position in Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,469 shares of the company's stock, valued at approximately $505,000.

A number of other institutional investors have also made changes to their positions in the business. Graham Capital Management L.P. lifted its position in shares of Encompass Health by 3.1% in the fourth quarter. Graham Capital Management L.P. now owns 35,750 shares of the company's stock worth $3,302,000 after purchasing an additional 1,067 shares in the last quarter. Focus Partners Wealth bought a new stake in shares of Encompass Health in the fourth quarter worth $649,000. Ensign Peak Advisors Inc lifted its position in shares of Encompass Health by 51.3% in the fourth quarter. Ensign Peak Advisors Inc now owns 75,174 shares of the company's stock worth $6,942,000 after purchasing an additional 25,503 shares in the last quarter. Farallon Capital Management LLC lifted its position in shares of Encompass Health by 15,266.7% in the fourth quarter. Farallon Capital Management LLC now owns 461,000 shares of the company's stock worth $42,573,000 after purchasing an additional 458,000 shares in the last quarter. Finally, FORA Capital LLC bought a new stake in shares of Encompass Health in the fourth quarter worth $1,096,000. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

Shares of NYSE:EHC traded up $0.13 on Friday, hitting $118.74. The company had a trading volume of 388,011 shares, compared to its average volume of 699,207. Encompass Health Co. has a 1-year low of $82.74 and a 1-year high of $121.96. The stock has a market cap of $11.97 billion, a price-to-earnings ratio of 26.62, a P/E/G ratio of 2.31 and a beta of 0.91. The stock has a 50 day moving average price of $107.85 and a 200 day moving average price of $101.40. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. The company's quarterly revenue was up 10.6% on a year-over-year basis. Analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.57%. Encompass Health's dividend payout ratio is currently 14.05%.

Insider Buying and Selling at Encompass Health

In related news, EVP John Patrick Darby sold 10,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares in the company, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock worth $16,034,082 over the last ninety days. Insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on EHC shares. Royal Bank of Canada boosted their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. UBS Group upped their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Truist Financial reaffirmed a "buy" rating and set a $135.00 price target (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, KeyCorp upped their price target on shares of Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.